Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Midlife milk consumption and substantia nigra neuron density at death.

Abbott RD, Ross GW, Petrovitch H, Masaki KH, Launer LJ, Nelson JS, White LR, Tanner CM.

Neurology. 2016 Feb 9;86(6):512-9. doi: 10.1212/WNL.0000000000002254. Epub 2015 Dec 9.

2.

Bowel movement frequency in late-life and substantia nigra neuron density at death.

Petrovitch H, Abbott RD, Ross GW, Nelson J, Masaki KH, Tanner CM, Launer LJ, White LR.

Mov Disord. 2009 Feb 15;24(3):371-6. doi: 10.1002/mds.22360.

3.

Marinesco bodies and substantia nigra neuron density in Parkinson's disease.

Abbott RD, Nelson JS, Ross GW, Uyehara-Lock JH, Tanner CM, Masaki KH, Launer LJ, White LR, Petrovitch H.

Neuropathol Appl Neurobiol. 2017 Dec;43(7):621-630. doi: 10.1111/nan.12419. Epub 2017 Jul 9.

PMID:
28626918
4.

Parkinsonian signs and substantia nigra neuron density in decendents elders without PD.

Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, Hardman J, Launer L, Masaki K, Tanner CM, White LR.

Ann Neurol. 2004 Oct;56(4):532-9.

PMID:
15389895
5.

Brain organochlorines and Lewy pathology: the Honolulu-Asia Aging Study.

Ross GW, Duda JE, Abbott RD, Pellizzari E, Petrovitch H, Miller DB, O'Callaghan JP, Tanner CM, Noorigian JV, Masaki K, Launer L, White LR.

Mov Disord. 2012 Sep 15;27(11):1418-24. doi: 10.1002/mds.25144. Epub 2012 Sep 13.

6.

[Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].

Wakabayashi K, Takahashi H, Oyanagi K, Ikuta F.

No To Shinkei. 1993 Nov;45(11):1033-8. Japanese. Erratum in: No To Shinkei 1993 Dec;45(12):1133.

PMID:
8135950
7.

Milk consumption and the risk of nigral degeneration.

Chen H, Marder K.

Neurology. 2016 Feb 9;86(6):496-7. doi: 10.1212/WNL.0000000000002268. Epub 2015 Dec 9. No abstract available.

PMID:
26658908
8.

Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.

Milber JM, Noorigian JV, Morley JF, Petrovitch H, White L, Ross GW, Duda JE.

Neurology. 2012 Dec 11;79(24):2307-14. doi: 10.1212/WNL.0b013e318278fe32. Epub 2012 Nov 14.

9.

Nigral pathology and parkinsonian signs in elders without Parkinson disease.

Buchman AS, Shulman JM, Nag S, Leurgans SE, Arnold SE, Morris MC, Schneider JA, Bennett DA.

Ann Neurol. 2012 Feb;71(2):258-66. doi: 10.1002/ana.22588.

10.

Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease.

Brown DF, Dababo MA, Bigio EH, Risser RC, Eagan KP, Hladik CL, White CL 3rd.

J Neuropathol Exp Neurol. 1998 Jan;57(1):39-46.

PMID:
9600196
11.

Ageing and Parkinson's disease: substantia nigra regional selectivity.

Fearnley JM, Lees AJ.

Brain. 1991 Oct;114 ( Pt 5):2283-301.

PMID:
1933245
12.

Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.

Hill WD, Arai M, Cohen JA, Trojanowski JQ.

J Comp Neurol. 1993 Mar 15;329(3):328-36.

PMID:
8459049
13.

Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.

Tompkins MM, Basgall EJ, Zamrini E, Hill WD.

Am J Pathol. 1997 Jan;150(1):119-31.

14.

Bowel movement frequency in late-life and incidental Lewy bodies.

Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, Launer LJ, Curb JD, White LR.

Mov Disord. 2007 Aug 15;22(11):1581-6.

PMID:
17523195
15.

Consumption of milk and calcium in midlife and the future risk of Parkinson disease.

Park M, Ross GW, Petrovitch H, White LR, Masaki KH, Nelson JS, Tanner CM, Curb JD, Blanchette PL, Abbott RD.

Neurology. 2005 Mar 22;64(6):1047-51.

PMID:
15781824
16.

Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.

Yamamoto S, Fukae J, Mori H, Mizuno Y, Hattori N.

Neurosci Lett. 2006 Apr 3;396(3):187-91. Epub 2005 Dec 28.

PMID:
16386370
17.

Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.

Greffard S, Verny M, Bonnet AM, Beinis JY, Gallinari C, Meaume S, Piette F, Hauw JJ, Duyckaerts C.

Arch Neurol. 2006 Apr;63(4):584-8.

PMID:
16606773
18.

A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.

Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C.

Neurobiol Aging. 2010 Jan;31(1):99-103. doi: 10.1016/j.neurobiolaging.2008.03.015. Epub 2008 May 23.

PMID:
18457903
19.

Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease.

Buchman AS, Nag S, Shulman JM, Lim AS, VanderHorst VG, Leurgans SE, Schneider JA, Bennett DA.

Mov Disord. 2012 Nov;27(13):1625-31. doi: 10.1002/mds.25142. Epub 2012 Oct 4.

20.

Clinical parkinsonism in dementia patients with substantia nigra Lewy bodies.

Ala TA, Yang KH, Sung JH, Frey WH 2nd.

J Neural Transm (Vienna). 1999;106(1):47-57.

PMID:
10195334

Supplemental Content

Support Center